Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 2/20 | 0.45 |
| ▸ | VNN1 | O95497 | 4/20 | 0.43 |
| ▸ | NSD2 | O96028 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | ALPG | P10696 | 2/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | P4HB | P07237 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL907865 | 0.87 | MAPK14 (0.46) | MAPK14VNN1NSD2LMNASMN1; SMN2 | |
| Bromide SCHEMBL3619165 | 0.86 | MAPK14 (0.45) | MAPK14VNN1NSD2LMNASMN1; SMN2 | |
| SCHEMBL12960530 | 0.84 | LTA4H (0.42) | MEN1KMT2A | |
| SCHEMBL11896950 | 0.83 | MAPK14 (0.43) | MAPK14VNN1NSD2LMNASMN1; SMN2 | |
| SCHEMBL1653812 | 0.82 | MAPK14 (0.42) | MAPK14VNN1NSD2LMNASMN1; SMN2 | |
| SCHEMBL12960529 | 0.78 | MAPT (0.44) | LMNASMN1; SMN2ALDH1A1HTTTDP1 | |
| SCHEMBL5544419 | 0.78 | MAPK14 (0.39) | MAPK14VNN1NSD2ALDH1A1ESR1 | |
| SCHEMBL4080048 | 0.78 | VNN1 (0.51) | MAPK14VNN1NSD2LMNASMN1; SMN2 | |
| SCHEMBL6834830 | 0.77 | FLT1 (0.37) | LMNAALDH1A1HTTGSK3BMEN1 | |
| Formaldehyde SCHEMBL5544617 | 0.76 | MAPK14 (0.38) | MAPK14VNN1NSD2ALDH1A1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6753433-B2 | CITALOPRAM; HALOGENATING 5-CYANOPHTHALIDE TO FORM 2-(HALOMETHYL)-4-CYANOBENZOYL HALIDE; REACTION WITH P-FLUOROPHENYL- BORANE OR METAL HALIDE; REACTING WITH 3-(DIMETHYLAMINO)PROPYLMETAL HALIDE | ORION CORPORATION, FERMION (FI) | 2004-06-22 | — | — | US | claimed |
| EP-1355897-A1 | PROCESS FOR THE PREPARATION OF 1-(3-DIMETHYLAMINOPROPYL)-1-(4-FLUOROPHENYL)-1,3-DIHYDROISOBENZOFURAN-5-CARBONITRILE | ORION CORPORATION FERMION (FI) | 2003-10-29 | — | — | EP | claimed |
| US-20030130527-A1 | Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile | ORION CORPORATION FERMION (FI) | 2003-07-10 | — | — | US | claimed |
| US-20020115872-A1 | Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-Fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile | ORION CORPORATION FERMION (FI) | 2002-08-22 | — | — | US | claimed |
| WO-2002060886-A1 | PROCESS FOR THE PREPARATION OF 1-(3-DIMETHYLAMINOPROPYL)-1-(4-FLUOROPHENYL)-1,3-DIHYDROISOBENZOFURAN-5-CARBONITRILE | ORION CORPORATION, FERMION (FI) | 2002-08-08 | — | — | WO | claimed |
| US-20120252784-A1 | 2,3,4-BENZOTHIADIAZEPINE-2,2-DIOXIDE DERIVATIVES | EGIS GYOGYSZERGYAR NYILVANOSAN MUEKOEDOE RESZVENYTARSASAG (HU) | 2012-10-04 | — | — | US | disclosed |
| US-20120252784-A1 | 2,3,4-BENZOTHIADIAZEPINE-2,2-DIOXIDE DERIVATIVES | EGIS GYOGYSZERGYAR NYILVANOSAN MUEKOEDOE RESZVENYTARSASAG (HU) | 2012-10-04 | — | — | US | disclosed |
| US-20050209467-A1 | Process for the preparation of 1 - (3-dimethylaminopropyl) -1 - (4-fluorophenyl) -1,3-dihydroisobenzofuran-5-carbonitrile | FERMION OY (FI) | 2005-09-22 | — | — | US | disclosed |
| US-6753433-B2 | CITALOPRAM; HALOGENATING 5-CYANOPHTHALIDE TO FORM 2-(HALOMETHYL)-4-CYANOBENZOYL HALIDE; REACTION WITH P-FLUOROPHENYL- BORANE OR METAL HALIDE; REACTING WITH 3-(DIMETHYLAMINO)PROPYLMETAL HALIDE | ORION CORPORATION, FERMION (FI) | 2004-06-22 | — | — | US | disclosed |
| WO-2004011450-A1 | PROCESS FOR THE PREPARATION OF 1-(3-DIMETHYLAMINOPROPYL) -1-(4-FLUOROPHENYL) -1,3-DIHYDROISOBENZOFURAN -5-CARBONITRILE | ORION CORPORATION FERMION (FI) | 2004-02-05 | — | — | WO | disclosed |
| EP-1355897-A1 | PROCESS FOR THE PREPARATION OF 1-(3-DIMETHYLAMINOPROPYL)-1-(4-FLUOROPHENYL)-1,3-DIHYDROISOBENZOFURAN-5-CARBONITRILE | ORION CORPORATION FERMION (FI) | 2003-10-29 | — | — | EP | disclosed |
| US-20030130527-A1 | Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile | ORION CORPORATION FERMION (FI) | 2003-07-10 | — | — | US | disclosed |
| US-6579993-B2 | Halogenating 5-cyanophthalide to a cyanobenzeneacyl halide derivative reacted with organometallic 4-fluorophenyl halides and 4-fluorophenylboranes to a biphenyl ketone reacted with an organometallic 3-dimethylaminopropyl halide | ORION CORPORATION, FERMION (FI) | 2003-06-17 | — | — | US | disclosed |
| US-20020115872-A1 | Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-Fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile | ORION CORPORATION FERMION (FI) | 2002-08-22 | — | — | US | disclosed |
| WO-2002060886-A1 | PROCESS FOR THE PREPARATION OF 1-(3-DIMETHYLAMINOPROPYL)-1-(4-FLUOROPHENYL)-1,3-DIHYDROISOBENZOFURAN-5-CARBONITRILE | ORION CORPORATION, FERMION (FI) | 2002-08-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115872-A1 | Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-Fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile | CYP2F1, CYP4F3, CYP4F2 | MAPK14 3535/4885VNN1 1659/4885NSD2 1652/4885 |
| US-20030130527-A1 | Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile | CYP2F1, CYP4F3, CYP4F2 | MAPK14 3530/4885VNN1 1634/4885NSD2 1583/4885 |
| US-20120252784-A1 | 2,3,4-BENZOTHIADIAZEPINE-2,2-DIOXIDE DERIVATIVES | BACE2, BACE1, HTR2C | MAPK14 1718/4885VNN1 2005/4885NSD2 674/4885 |
| US-20050209467-A1 | Process for the preparation of 1 - (3-dimethylaminopropyl) -1 - (4-fluorophenyl) -1,3-dihydroisobenzofuran-5-carbonitrile | CYP4F2, CYP4F3, CYP4F12 | MAPK14 2587/4885VNN1 1549/4885NSD2 1788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.